Is a Cancer Vaccine on the Horizon? Merck and Moderna Hope So
A personalized cancer vaccine from Merck and Moderna has cleared a major hurdle: It succeeded in a large Phase 3 clinical trial, potentially putting the experimental treatment on a path…
A personalized cancer vaccine from Merck and Moderna has cleared a major hurdle: It succeeded in a large Phase 3 clinical trial, potentially putting the experimental treatment on a path…